Finasterid Winthrop

Finasterid Winthrop may be available in the countries listed below.

Ingredient matches for Finasterid Winthrop

Finasteride

Finasteride is reported as an ingredient of Finasterid Winthrop in the following countries:

• Germany

International Drug Name Search

Cefepima

Cefepima may be available in the countries listed below.

Ingredient matches for Cefepima

Cefepime

Cefepime is reported as an ingredient of Cefepima in the following countries:

• Peru

International Drug Name Search

Glimepiride Winthrop

Glimepiride Winthrop may be available in the countries listed below.

Ingredient matches for Glimepiride Winthrop

Glimepiride

Glimepiride is reported as an ingredient of Glimepiride Winthrop in the following countries:

• Estonia


• Latvia


• Netherlands


• Switzerland

International Drug Name Search

Youaneto

Youaneto may be available in the countries listed below.

Ingredient matches for Youaneto

Aldioxa

Aldioxa is reported as an ingredient of Youaneto in the following countries:

• Japan

International Drug Name Search

Ecosal

Ecosal may be available in the countries listed below.

Ingredient matches for Ecosal

Salbutamol

Salbutamol is reported as an ingredient of Ecosal in the following countries:

• Latvia

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Ecosal in the following countries:

• Belgium


• Bulgaria


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• Hungary


• Serbia


• Slovakia

International Drug Name Search

Duraclon

Pronunciation: KLON-i-deen
Generic Name: Clonidine
Brand Name: Duraclon

Duraclon is not recommended for treating pain during or following childbirth, or that associated with surgery because of the risk of developing very low blood pressure and an unusually slow heartbeat. However, there may be rare situations in which the potential benefits may outweigh the possible risks. Contact your doctor for more details.

Duraclon is used for:

Treating severe pain along with opioid (narcotic) pain medicines in certain cancer patients. It may also be used for other conditions as determined by your doctor.

Duraclon is an alpha-agonist analgesic. It works in the spinal cord by preventing pain signal transmission to the brain.

Do NOT use Duraclon if:

• you are allergic to any ingredient in Duraclon


• you have bleeding problems


• you have an infection at the injection site


• you are taking an anticoagulant (eg, warfarin, heparin)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Duraclon:

Some medical conditions may interact with Duraclon. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of kidney problems, blood vessel problems (eg, in the brain), heart problems, high or low blood pressure, the blood disease porphyria, or mental or mood problems (eg, depression)


• if you have low blood volume or you have had a stroke or a recent heart attack


• if you are scheduled for surgery

Some MEDICINES MAY INTERACT with Duraclon. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulant therapy (eg, warfarin, heparin) because the risk of bleeding at the injection site may be increased


• Beta-blockers (eg, propranolol), calcium channel blockers (eg, verapamil), or digoxin because the risk of slow or irregular heartbeat may be increased


• Tricyclic antidepressants (eg, amitriptyline) because they may decrease Duraclon's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Duraclon may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Duraclon:

Use Duraclon as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Duraclon is usually given by continuous epidural infusion devices at your doctor's office, hospital, or clinic. If you will be using Duraclon at home, a health care provider will teach you how to use it. Be sure you understand how to use Duraclon. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• Do not use Duraclon if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• Do not suddenly stop taking Duraclon. You may have an increased risk of side effects. If you need to stop Duraclon, your doctor will gradually lower your dose. Contact your doctor right away if the medicine infusion is interrupted for any reason.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Duraclon, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Duraclon.

Important safety information:

• Duraclon may cause drowsiness, dizziness, or light-headedness. These effects may be worse if you take it with alcohol or certain medicines. Use Duraclon with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Duraclon; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Duraclon may cause dizziness, light-headedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Do not suddenly stop taking Duraclon. Doing so may cause withdrawal symptoms like nervousness, irritability, or shakiness. You could also get a headache and high blood pressure. The risk of these effects may be greater if you have been taking high doses of Duraclon. The risk may also be greater if you are taking a beta-blocker (eg, atenolol). Rarely, very serious effects like increased blood pressure in the brain, stroke, and death have occurred in patients who have suddenly stopped using Duraclon. Discuss any questions or concerns with your doctor.


• Duraclon may cause low blood pressure. This effect has occurred most often within the first 4 days after starting Duraclon, although it may occur at any time while using Duraclon. The risk may be higher in women and in lower weight patients. Contact your doctor right away if you experience symptoms of low blood pressure (eg, fainting, light-headedness, severe or persistent dizziness).


• Tell your doctor or dentist that you take Duraclon before you receive any medical or dental care, emergency care, or surgery.


• Lab tests, including blood pressure, may be performed while you use Duraclon. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Duraclon should be used with extreme caution in CHILDREN; use is limited to children old enough to tolerate placement and management of an epidural catheter.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Duraclon while you are pregnant. Duraclon is found in breast milk. Do not breast-feed while using Duraclon.

If you stop taking Duraclon suddenly, you may have WITHDRAWAL symptoms. These may include nervousness, agitation, headache, tremor, and rapid increase in blood pressure.

Possible side effects of Duraclon:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Anxiety; confusion; constipation; dizziness; drowsiness; dry mouth; general weakness; nausea; ringing in the ears; sweating; tiredness; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; depression; fainting; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; hallucinations; light-headedness; painful or difficult urination; severe or persistent dizziness; shortness of breath; slow or shallow breathing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Duraclon side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Accidental overdose of Duraclon is an increasing cause of poisoning in children 3 years old and younger. Symptoms may include decreased or absent reflexes; difficult or slow breathing; drowsiness; irritability; pinpoint pupils; seizures; severe or persistent headache; slow or irregular heartbeat; symptoms of hypothermia (eg, shivering, sluggishness, confusion, mental or mood changes, coma); symptoms of low blood pressure (eg, fainting; light-headedness; severe dizziness).

Proper storage of Duraclon:

Duraclon is usually handled and stored by a health care provider. If you are using Duraclon at home, store Duraclon as directed by your pharmacist or health care provider. Keep Duraclon out of the reach of children and away from pets.

General information:

• If you have any questions about Duraclon, please talk with your doctor, pharmacist, or other health care provider.


• Duraclon is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duraclon. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duraclon resources

• Duraclon Side Effects (in more detail)
• Duraclon Use in Pregnancy & Breastfeeding
• Duraclon Drug Interactions
• Duraclon Support Group
• 0 Reviews for Duraclon - Add your own review/rating

• Duraclon Advanced Consumer (Micromedex) - Includes Dosage Information


• Duraclon Prescribing Information (FDA)


• Catapres Consumer Overview


• Catapres Advanced Consumer (Micromedex) - Includes Dosage Information


• Catapres Prescribing Information (FDA)


• Clonidine Monograph (AHFS DI)


• Kapvay Consumer Overview


• Kapvay Prescribing Information (FDA)


• Nexiclon XR Prescribing Information (FDA)

Compare Duraclon with other medications

• Pain
• Postanesthetic Shivering

Zitrocin

Zitrocin may be available in the countries listed below.

Ingredient matches for Zitrocin

Azithromycin

Azithromycin is reported as an ingredient of Zitrocin in the following countries:

• Tunisia

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Zitrocin in the following countries:

• Czech Republic


• Hungary


• Slovakia


• Slovenia

International Drug Name Search

Voltaren Dolo Filmtabletten

Voltaren Dolo Filmtabletten may be available in the countries listed below.

Ingredient matches for Voltaren Dolo Filmtabletten

Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren Dolo Filmtabletten in the following countries:

• Austria


• Switzerland

International Drug Name Search

Rifapentine

In the US, Rifapentine (rifapentine systemic) is a member of the drug class rifamycin derivatives and is used to treat Tuberculosis, Active.

US matches:

• Rifapentine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AB05

CAS registry number (Chemical Abstracts Service)

0061379-65-5

Chemical Formula

C47-H64-N4-O12

Molecular Weight

877

Therapeutic Categories

Antibacterial

Antitubercular agent

Chemical Name

Rifamycin, 3-[[4-cyclopentyl-1-piperazinyl)imino]methyl]-

Foreign Names

• Rifapentinum (Latin)
• Rifapentin (German)
• Rifapentine (French)
• Rifapentina (Spanish)

Generic Names

• Rifapentina (OS: DCIT)
• Rifapentine (OS: USAN, BAN)
• DL 473 (IS)
• DL 473-IT (IS)
• L 11473 (IS)
• MDL 473 (IS)
• R 773 (IS)

Brand Name

• Priftin
  Sanofi-Aventis, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Topron

Topron may be available in the countries listed below.

Ingredient matches for Topron

Nifuroxazide

Nifuroxazide is reported as an ingredient of Topron in the following countries:

• Dominican Republic


• El Salvador


• Guatemala


• Mexico


• Nicaragua


• Panama

International Drug Name Search

Amloratio

Amloratio may be available in the countries listed below.

Ingredient matches for Amloratio

Amlodipine

Amlodipine is reported as an ingredient of Amloratio in the following countries:

• Poland

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amloratio in the following countries:

• Sweden

International Drug Name Search

Lidocaina Infosint

Lidocaina Infosint may be available in the countries listed below.

Ingredient matches for Lidocaina Infosint

Lidocaine

Lidocaine is reported as an ingredient of Lidocaina Infosint in the following countries:

• Romania

International Drug Name Search

Lamuran

Lamuran may be available in the countries listed below.

Ingredient matches for Lamuran

Raubasine

Raubasine is reported as an ingredient of Lamuran in the following countries:

• Italy

International Drug Name Search

Cofamix Ampicilline

Cofamix Ampicilline may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cofamix Ampicilline

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Cofamix Ampicilline in the following countries:

• France

International Drug Name Search

Multifung

Multifung may be available in the countries listed below.

Ingredient matches for Multifung

Bifonazole

Bifonazole is reported as an ingredient of Multifung in the following countries:

• Chile

International Drug Name Search